Belzutifan-Based Combinations Meet DFS, PFS End Points in Renal Cell Carcinoma | OncLive Two belzutifan-based combinations met their respective primary efficacy end points of DFS and PFS in the phase 3 LITESPARK-022 and LITESPARK-011 trials.

Belzutifan-Based Combinations Meet DFS, PFS End Points in Renal Cell Carcinoma #oncology #RCC #GUoncology
www.onclive.com/view/belzuti...

🎥 New on #OncologyBytes

Dr Banna & Dr Kanesvaran reflect on a record-breaking urology cancer summit:

🧠 Mini-orals, 1100+ global participants, new IUCS Association

📺 Watch: youtu.be/Z-Q4xr0F6tY

#ONCOassist #PrecisionOncology #CancerCare #GUoncology #ONCOassist #CancerCare #IUCS2025 #Oncoalert
]

🎥 New on #OncologyBytes

Dr. Petros Grivas at #IUCS2025 discusses global equity, biomarkers, & patient-centeed care in GU cancers.

“Collaboration is key to moving the field forward.”

📺 Watch: youtu.be/hB-__9aagnU

#ONCOassist #PrecisionOncology #CancerCare #GUoncology #ONCOassist #CancerCare

What were the key takeaways from today’s proffered paper session on GU tumors, prostate, penile, and testicular cancers at #ESMO25? Read our thread below to get the updates you need to know from @dmukherji.bsky.social, Derya Tilki and colleagues #OncSky #MedSky #ProstateCancer #GUOncology

Belzutifan Plus Pembrolizumab and Lenvatinib Improves Efficacy in Advanced Clear Cell RCC | OncLive OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Belzutifan Plus Pembrolizumab and Lenvatinib Improves Efficacy in Advanced Clear Cell #RCC #ESMO25 #KidneyCancer #GUoncology

www.onclive.com/view/belzuti...

Combining Durvalumab With BCG Yields Significant DFS Benefit vs BCG Alone in BCG-Naive NMIBC | OncLive Durvalumab plus BCG induction and maintenance therapy yielded clinically meaningful improvement in DFS vs BCG induction and maintenance therapy alone in BCG-naive, high-risk NMIBC.

Combining Durvalumab With BCG Yields Significant DFS Benefit vs BCG Alone in BCG-Naive #NMIBC #ESMO25 #oncology #GUoncology

www.onclive.com/view/combini...

Episode 12: Variant Histology Treatment Considerations From World GU 2025 | CancerNetwork Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.

🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded.
🔗 www.cancernetwork.com/view/episode...
#SCRI #CancerResearch #GUOncology #OncologyDecoded

#ProstateCancerResearch #ProstateCancerTreatment
#GUOncology #RadiationOncology #RadOnc #MRIGuidedRadiation #CancerCare #CancerResearch #OncologyInnovation #QualityOfLife

👉 Registration for #EMUC25 is OPEN!
Join the leading GU cancers congress in Prague, 13–16 Nov 2025.
🔹 Multidisciplinary programme
🔹 Networking with global experts
🔹 Discounted fees until 30 Oct

🔗 Register now: buff.ly/CJbS5HR

#GUoncology #MedicalCongress #OncologyResearch

📣 EMUC25 – Register now!
⏰ Discounted fees until 30 October. Don’t miss a leading GU cancers congress.

🔗 buff.ly/BlhJMRF

#EMUC25 #GUoncology #MedicalCongress #OncologyResearch #EAU #ESTRO

Registration | Société Internationale d'Urologie

📅 Add the B2B to your Congress schedule: Friday, October 31
🎯 Don’t miss out on early registration rates!
📌 Register BEFORE June 30 and SAVE up to 200 €! bit.ly/3E2ir3Z

We look forward to welcoming you for an all-day programme dedicated to key advances in #GUOncology.

The #ASCO25 #OncoAlertTOP10 Abstracts in #GUOncology These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸
#ProstateCancer #BladderCancer #kidneyCancer

Thread by @EdmondMKwan on Thread Reader App @EdmondMKwan: On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the @ANZUPtrials phase II TheraP study, now published in @NatureMedicine. Massive effort supported...

Amazing work by Ed Kwan and team, well done!
@anzuptrials.bsky.social @monashuniversity.bsky.social @easternhealthau.bsky.social @drmhofman.bsky.social @pcf-science.bsky.social #MonashBDI #EHCSMonash #AlexWyatt #ArunAzad #VanProstateCtr #PCFA #ASCO25 #TheraP #ProstateCancer #pcsm #GUOncology

Missed the 6th #B2BGUCancersTriad at #SIU2024NewDelhi? Read the meeting proceedings in the latest issue of #SIUJ and on #SIUAcademy for a full recap of the main advances in #GUoncology from 2024.
Access now: bit.ly/4gXX1CD

#OpenAccess #Journal #Urology #Urooncology #UroSoMe

The Proceedings from the 6th #B2BGUCancersTriad Meeting are available in the latest #SIUJ issue and the #SIUAcademy. Discover recent advances in #GUoncology presented at #SIU2024NewDelhi.

📖 Access the full proceedings here: bit.ly/4gXX1CD

#OpenAccess #Journal #Urology #Urooncology

Review the main advances in #GUoncology from 2024. Explore the proceedings from the 6th #B2BGUCancersTriad Meeting, available now in the latest #SIUJ issue and the #SIUAcademy: bit.ly/4gXX1CD
#OpenAccess #SIU2024NewDelhi

Missed the 6th #B2BGUCancersTriad at #SIU2024NewDelhi? Read the meeting proceedings in the latest issue of #SIUJ and on #SIUAcademy for a full recap of the main advances in #GUoncology from 2024.
Access now: bit.ly/4gXX1CD
#OpenAccess #Journal #Urology #Urooncology #UroSoMe

Petros Grivas: TROPiCS04 P3 trial data has been published - OncoDaily Petros Grivas: TROPiCS04 P3 trial data has been published / A. Necchi, C. Vulsteke, C.N. Sternberg, C.S. Sima, cancer, F. Boateng, I. Durán, J. Bellmunt, J.

TROPiCS04 P3 trial data has been published - Petros Grivas

oncodaily.com/insight/petr...

#Cancer #CancerResearch #UrothelialCarcinoma #ClinicalTrial #GUOncology #Medicine #Health #Oncology #OncoDaily

Closing day of attending  @brighamandwomens.bsky.social @Dana- with this year’s amazing BWH/BIDMC housestaff!  Breadth of cases to learn from in and outside #GUoncology and comfort zone! Now, taking a moment with Wally (Red Sox) at end of rotation!

FDA Approvals for GU Cancers in 2024: Advancing Treatment Options!
#GUOncology #Cancer #FDA #Oncology @oncoalert.bsky.social @uroweb.bsky.social @oncbrothers.bsky.social
@drchoueiri.bsky.social @viveksubbiah.bsky.social
@erplimackmd.bsky.social
@charlesryanmd.bsky.social @gu-cast.bsky.social

#Genitourinary #Oncology #GUonc #GUoncol #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Oncsky #Medtwitter

go.bsky.app/DtoXvaD

Petros Grivas: GU oncologist Position at Fred Hutchinson Cancer Center - OncoDaily Petros Grivas: GU oncologist Position at Fred Hutchinson Cancer Center / cancer, Fred Hutchinson Cancer Center, GU Oncology, OncoDaily, Oncology, Petros Grivas

GU oncologist Position at Fred Hutchinson Cancer Center - Petros Grivas

oncodaily.com/career/214637

#Cancer #FredHutchinsonCancerCenter #GUOncology #OncoDaily #Oncology #Medicine #Health

Sadly sharing in the grief after the death of Felix Feng, MD, an extraordinary @ucsfhealth.bsky.social physician-scientist and beloved colleague/mentor to many in the Hematology/Oncology Division at @ucsfcancer.bsky.social. A profound loss for us and for cancer research. #RadOnc #GUOncology #Cancer

Great review! NECTIN4 is an exciting target. More to come !
#cancer #jcoprecisionmedicine #bladdercancer #guoncology #biomarker

85 people in here now, and growing - come and join us!

#Genitourinary #Oncology #GUonc #GUoncol #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Oncsky #Medtwitter

go.bsky.app/DtoXvaD

As many know in the #Guoncology field we need biomarkers! Patients are eager and we know important work is being done to study KIM-1 and others!

One of the most difficult things for patients to grasp is the idea many patients don’t reoccur after surgery!

Anxiety is still there

#Oncsky #Cansky

66 names on this list now and growing every day - jump on!

go.bsky.app/DtoXvaD

#Genitourinary #Oncology #GUonc #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Medtwitter

More starter packs for #guoncology 👏🏻👏🏻 For my #kidneycancer patients out there 🫶🏻

#oncosky #cansky